Correction to: Enhancing apoptosis-mediated anticancer activity of evodiamine through protein-based nanoparticles in breast cancer cells (Scientific Reports, (2024), 14, 1, (2595), 10.1038/s41598-024-51970-3)

0Citations
Citations of this article
N/AReaders
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Correction to: Scientific Reportshttps://doi.org/10.1038/s41598-024-51970-3, published online 31 January 2024 The original version of this Article contained errors in Figure 7 and the Supplementary Figures 7, 8 and 9 where the molecular weight of Bax and the molecular weight of Bcl-2 were incorrect. The correct molecular weight of Bax is 20 kDa and molecular weight of Bcl-2 is 28 kDa. The original Figure 7, accompanying legend and Supplementary Information file appear below. (Figure presented.) The caption to be typeset alongside it: Western blot analysis. The protein expression changes of p53, Bax and Bcl-2 in MDA-MB-231 cells (a) and MCF-7 cells (b) after treatment with BNPs, EVO, and ENPs for 24 h. These errors have now been corrected in the original Article and in the Supplementary Information 1 file that accompanies the original Article.

Cite

CITATION STYLE

APA

Solanki, R., Rajput, P. K., Jodha, B., Yadav, U. C. S., & Patel, S. (2024, December 1). Correction to: Enhancing apoptosis-mediated anticancer activity of evodiamine through protein-based nanoparticles in breast cancer cells (Scientific Reports, (2024), 14, 1, (2595), 10.1038/s41598-024-51970-3). Scientific Reports. Nature Research. https://doi.org/10.1038/s41598-024-56762-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free